Haemonetics HAE Income Statement
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| $1.33B-2.0% | $1.36B+4.0% | $1.31B+12.0% | $1.17B+17.7% | ||
| $546.44M-10.7% | $611.87M-0.9% | $617.51M+11.6% | $553.56M+13.5% | ||
| $787.59M+5.2% | $748.96M+8.3% | $691.55M+12.4% | $615.1M+21.7% | ||
| 59%+4.0pp | 55%+2.2pp | 52.8%+0.2pp | 52.6%+1.7pp | ||
| $59.77M-4.7% | $62.72M+15.2% | $54.44M+8.6% | $50.13M+7.1% | ||
| $442.42M+1.3% | $436.79M+1.6% | $429.78M+14.1% | $376.68M+10.7% | ||
| $111.72M-3.3% | $115.59M+18.9% | $97.22M+100% | $48.52M-20.1% | ||
| $630.85M+19.7% | $527.14M+0.1% | $526.67M+14.7% | $459.06M+8.1% | ||
| —— | $221.82M+34.5% | $164.88M+5.7% | $156.03M+93.2% | ||
| -$28.7M-195% | -$9.75M+25.1% | -$13.02M+11.0% | -$14.63M+14.5% | ||
| —— | $212.07M+39.6% | $151.87M+7.4% | $141.4M+122% | ||
| —— | $44.39M+29.4% | $34.31M+31.9% | $26M+28.4% | ||
| —— | $167.68M+42.6% | $117.56M+1.9% | $115.4M+166% | ||
| —— | $3.31+44.5% | $2.29+2.7% | $2.23+165% | ||
| —— | $3.33+43.5% | $2.32+2.2% | $2.27+170% | ||
| 190.4M-6.8% | 204.2M-0.7% | 205.6M-0.1% | 205.9M+0.4% | ||
| 189.7M-6.3% | 202.5M-0.1% | 202.7M-0.4% | 203.5M-0.3% | ||
| $44M-8.8% | $48.26M+50.7% | $32.03M-1.9% | $32.64M-31.2% | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $86.55M+3,520% | $2.39M-77.1% | $10.42M— | —— | ||
| —— | —— | $44.58M+12.0% | $39.82M— | ||
| $14.88M+314% | -$6.96M— | —— | $24.42M-30.2% | ||
| -$47.36M-173% | $64.7M+7.7% | $60.06M— | —— | ||
| $35.03M— | —— | $34.05M+52.4% | $22.33M+48.7% | ||
| -$180.49M— | —— | —— | -$100.36M-537% | ||
| -$179.55M— | —— | -$322.39M-124% | -$143.79M-66.5% | ||
| $293.22M+61.4% | $181.73M-0.3% | $182.29M-33.2% | $273.06M+58.5% | ||
| -$28.7M-195% | -$9.75M+25.1% | -$13.02M+11.0% | -$14.63M+14.5% | ||
| $10.73M+7.5% | $9.98M-14.2% | $11.63M+24.8% | $9.32M— | ||
| —— | —— | —— | $75M— | ||
| $0— | —— | $0-100% | $1.12M— | ||
| $32.78M-16.5% | $39.28M+3.0% | $38.13M-80.1% | $191.33M+98.2% | ||
| -$102K+59.0% | -$249K+74.5% | -$976K-2,118% | -$44K— | ||
| $1.38M-94.1% | $23.25M+1,185% | $1.81M— | —— | ||
| —— | —— | $1.61M-39.0% | $2.64M+12.8% | ||
| —— | $4.69M-61.7% | $12.25M+27.3% | $9.63M-45.0% | ||
| —— | —— | —— | —— | ||
| $33.83M+14.1% | $29.64M+4.6% | $28.33M+10.7% | $25.58M+5.0% | ||
| —— | $221.82M+34.5% | $164.88M+5.7% | $156.03M+93.2% | ||
| —— | $337.4M+28.7% | $262.1M+5.1% | $249.34M+39.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Haemonetics's profit margins?
- Gross margin is 59.0% and operating margin is 19.0%, with a 13.3% net margin.
- Where does Haemonetics's income statement data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.